業績

2016年度 :: 学会発表 :: 国際学会 :: 業績

APASL 2017
2017.2. Shanghai, China


Kobayashi T, Suda G, Terashita K, Yamamoto Y, Nagasaka A, Furuya K, Nakai M, Sho T, Morikawa K, Ogawa K, Sakamoto N.
Add-on effects of fulvastatin in simeprevir, pegylated- interferon plus ribavirin convination therapy for patients with genotype 1 hepatitis C virus infection: a randomized control study.

Suda G, Tsukuda K, Ogawa K, Morikawa K, Sakamoto N.
L carnitin suppress hepatitis C virus assembly throgh anti- adepogenetic effect.

ECCO2017: European Cancer Congress
2017.1. Amsterdam, The Netherlands


Abiko S, Shimizu Y, Mizushima T, Matsuda K, Miyamoto S, Tsuda M, Yamamoto K, Ono S, Kudo T, Sakamoto N.
Clinical outcomes of endoscopic resection for head and neck cancers invading the subepithelial.

2017 Gastrointestinal Cancers Symposium (2017 ASCO-GI).
2017.1. San Francisco, USA


Kawamoto Y, Meguro T, Yuki S, Nakatsumi H, Sasaki T, Hatanaka K, Uebayashi M, Iwanaga I, Abe N, Nakamura M, Okuda H, Kazunori Eto K, Oba A, Abe M, Oba K, Satoh T, Sakata Y, Sakamoto N, Komatsu Y.
Phase II study of trastuzumab with irinotecan in HER2- positive metastatic or advanced gastric cancer patients previously treated with trastuzumab and failed: HGCSG1201/OGSG1205

Nakamura M, Yagisawa M, Sawada K, Muranaka T, Nakatsumi H, Kawamoto Y, Yuki S, DazaiM, Ishiguro A, Kobayashi Y, Sogabe S, Miyagishima T, Iwanaga I, Tateyama M, Hatanaka K, Ono K, Sakamoto N, Sakata Y, Komatsu Y.
A multicenter prospective study on the efficacy and safety of denosumab in gastrointestinal cancer patients receiving short-term periodic steroid premedication for prevention of chemotherapy-induced nausea and vomiting. (ESPRESSO-02/HGCSG1602 study)

Yagisawa M, Nakamura M, Matsuda C, Murai T, Itaya K, Sone T, Koike Y, Endo A, Tsukuda Y, Ono Y, Nagasaka A, Nishikawa S.
A retrospective analysis of eye disorders induced by chemotherapy including S-1 for gastrointestinal cancer.

ESMO Asia 2016 Conference
2016.12. Singapore, Singapore


Oba A, Nakamura M, Murai T, Matsuda C, Itaya K, Koike Y, Endo A, Tsukuda Y, Ono Y, Kudo T, Nagasaka A, Nishikawa S.
Thromboembolism in gastrointestinal tract cancer patients receiving chemotherapy: preplanned analysis of risk factors and survival.

Sasaki T, Yuki S, Kawamoto Y, Harada K, meguro T, Miyagishima T, Nakamura M0, Sato A, iwanaga I, Tateyama M, Hatanaka K, Eto K, Okuda H, O.Muto O, Abe M, Oba A, Kato S, Miyashita K, Y.Sakata Y, Y.Komatsu Y.
Observational cohort study of 1st line Bevacizumab combined with chemotherapy in metastatic colorectal cancer(HGCSG0802): Sub-group analysis by the Glasgow Prognostic Score(GPS).

APDW 2016
2016. 11. Kobe, Japan


Kato S, Sugiura R, Sano I, Kawakubo K, Kuwatani M, Sakamoto N.
A case of bile duct neuroendocrine tumor preoperatively diagnosed by endoscopic ultrasonography-guided fineneedle aspiration biopsy

Mabe K, Kato M.
The endoscopic futur e of non-Helicobacter pylori helicobacter gastritis.

Sato T.
Endoscopic obliterative therapy for gastric varices.

The 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
2016. 11. Munich, Germany


Harada K, Okamoto W, Minaki S, Kawamoto Y, Bando H, Yuki S, Yoshino T, Komatsu Y, Ohtsu A, Sakamoto N, Tsuchihara K.
Comparative sequence analysis between primary colorectal cancer, metastasis and recurrent metastasis after adjuvant FOLFOX chemotherapy.

AASLD 2016
2016. 11. Boston, USA


Hige S, Ozeki I, Tatsumi R, Yamaguchi M, Kimura M, Arakawa T, Nakajima T, Kuwata Y, Sato T, Ohmura T, Toyota J, Karino Y.
Serum concentration of asunaprevir affects alanine aminotransferase elevation for patients with chronic hepatitis C and the protective effects of ursodeoxycholic acid.

Karino Y, Karino Y, Hige S, Ozeki I, Tatsum R, Yamaguchi M, Kimura M, Arakawa T, Nakajima T, Kuwata Y, Sato T, Ohmura T, Toyota J, Hosaka T.
Analysis of the incidence of primary hepatocellular carcinoma in Japanese patients with hepatitis B virus infection stratified by primary liver cancer risk score at the start of entecavir therapy.

UEGW 2016
2016.10. Vienna, Austria


Mizusima T, Ohnishi S, Hosono H, Tsuda M, Onishi R, Sakamoto N.
Oral administration of conditioned medium obtained from mesenchymal stem cell culture prevents subsequent stricture formation after esophageal submucosal dissection in pigs.


Miyamoto S, Ohnishi S, Tsuchiya I, Onishi R, Hosono H, Takeda H, Sakamoto N.
Effects of human amnion-derived mesenchymal stem cell transplantation and conditioned medium enema in rats with trinitrobenzene sulfonic acid-induced colitis.

Sato T.
Recent trend of variceal bleeding in patients with portal hypertension and its treatments.

Shimizu Y, Goda K, Kato M, Dobashi A, Takahashi M, Kato M.
Observer agreement among novices in image assessment of Barrett's esophagus using a simplified narrow-band imaging classification: a retrospective multi-center study.

HCV Meeting 2016
2016.10. Kyoto, Japan


Suda G, Kudo M, Nagasaka A, Furuya K, Yamamoto Y, Kobayashi T, Shinada K , Tateyama M, Konno J, Tsukuda Y, Yamasaki K, Kimura M, Umemura M, Izumi T, Tsunematsu S, Sato F, Terasita K, Nakai M, Horimoto H, Sho T, Natsuizaka M, Morikawa K , Ogawa K, Sakamoto N.
Efficacy and safety of IFN-free direct acting antivirals therapy for patients with renal impairment.


Morikawa K, Suda G, Jerome GOUITTENOIRE, Darius MORADPOUR, Sakamoto N.
Analysis of cellular factors involved in the particle formation and secretion of hepatitis C virus.

ESMO 2016
2016.10. Copenhagen, Denmark


Muranaka T, Komatsu Y, SOhnish S, Sawada K, Harada K, Kawamoto Y, Nakatsumi H, Yuki S, Yagisawa M, Nakamura M, Kobayashi Y, Sogabe S, Miyagishima T, Sakamoto N.
The prospective study of relation between 5-HIAA/substance P and nausea/vomiting in patients receiving moderately emetogenic chemotherapy.

Nakamura M, Ishiguro A, Muranaka T, Yuki S, Ono K, Murai T, Matsuda C, Oba A, Itaya K, Yagisawa M, Koike Y, Endo A, Tsukuda Y, Ono Y, Kudo T, Nagasaka A, Nishikawa S, Yoshito Komatsu Y.
A prospective observational study of the impact on bone metabolism of short-term periodic steroid premedication of chemotherapy for gastrointestinal cancer. (ESPRESSO-01 study) : Pre-planed subgroup analysis

Ohnishi S, Watar H, Kanno M, Ohba Y, Takeuchi S, Miyaji T , Oyamada S, Nomura E, Kato H, Sugiyama T, Asaka M, Sakuragi N, Yamaguchi T, Uezono Y, Satoru Iwase S.
Efficacy of Rikkunshito, a Japanese herbal medicine, on chemotherapy-induced nausea and vomiting in patients with uterine cervical or corpus cancer treated with Cisplatin and Paclitaxel ?A randomized phase II study.

Yuki S, Komatsu Y, Muranaka T, Harada K, Sugiyama J, Tsuji Y, Ando T, Hosokawa A, Hatanaka K, Naruse H, Takahata T, Sato A, Kobayashi Y, Miyagishima T, Okuda H, Kudo M, Nakamura M, Hisai H, Sakamoto N, Sakata Y.
Phase II trial of panitumumab monotherapy for patients with KRAS exon2 wild type colorectal cancer after progression on cetuximab. HGCSG1101

Yuki S, Komatsu Y, Satake H, Miyamoto Y, Tanioka H, Tsuji A, Asayama M, Shiraishi T, Kotaka M, Makiyama A, Kashiwada T, Takeuchi N, Shimokawa M, Saeki H, Oki E, Emi Y, Baba H, Maehara Y.
Updated report: A randomized, double-blind, placebo- controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC):(KSCC1402/HGCSG1402)

4th International Conference of Federation of Asian Clinical Oncology
2016.9. Xiamen, China


Harada K, Yuki S, Tsuji Y, Hosokawa A, Nakamura M, Muto O, Sasaki T, Iwanaga I, Hatanaka K, Sato A, Takahashi Y, Sogabe S, Sakamoto N, Sakata Y, Komatsu Y.
Updated analysis : Phase II trial of Irinotecan/S-1/Cetuximab (IRIS/Cet) as second line treatment in patients with KRAS exon2 wild type metastatic colorectal cancer (mCRC): HGCSG0902. -Comparison of administration interval in Cetuximab treatment.

Nakatsumi H, Yuki S, Harada K, Muranaka T, Meguro T, Nakamura M, Iwanaga I, Oba A, Kudo M, Sogabe S, Ono K, Kudo K, Sakamoto N, Sakata Y, Komatsu Y.
Observational cohort study of first-line Bevacizumab with Oxaliplatin or Irinotecan and Fluoropyrimidines in metastatic colorectal cancer : HGCSG0802 : Analysis of early tumor shrinkage (ETS).

European Helicobacter and Microbiota Study Group XXIXth International Workshop
2016.9. Magdeburg, Germany


Ono S, Nakagawa S, Sakamoto N. Mabe K, Kato M.
Eradication of Helicobacter pylori infection using vonoprazanbased triple therapy in patients allergic to penicillin.

Tsuda M, Kato M, Ono S, Nakagawa S, Nishikawa K, Mabe K, Shimizu Y, Asaka M, Sakamoto N.
Effectiveness of H.pylori eradication in improving dyspeptic symptoms.

ISSCR 2016
2016.6. San Francisco, USA


Ohnishi S, Mizushima T, Hosono H, Tsuda M, Onishi R, Sakamoto N.
Conditioned medium obtained from amnion - derived mesenchymal stem cell culture prevents esophageal stricture after endoscopic submucosal dissection in pigs.

The 13th Korea-Japan joint Symposium on Helicobacter infection
2016. 6. Beppu, Japan


Mabe K, Okuda M, Kikuchi S, Takamasa M, Kato M, Asaka M.
Urine antibody test is suitable for screening of H. pylori infection in junior and senior high school students in Japan.

ESMO World Congress on Gastrointestinal Cancer 2016
2016. 6. Barcelona, Spain


Miyagishima T, Yuki S, Nakatsumi H, Kawamoto Y, Muranaka T, Sawada K, Kobayashi Y, Sasaki T, Nakamura M, Sato A, Iwanaga I, Tateyama M, Hatanaka K, Eto K, Okuda H, Muto O, Abe M, Kato S, Miyashita K, Sakata Y, Komatsu Y.
Observational cohort study of 1st line Bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Sub-group analysis by the Glasgow Prognostic Score (GPS).

Nakatsumi H, Komatsu Y, Sawada K, Muranaka T, Kawamoto Y, Yuki S, Sakamoto N.
Retrospective comparison of efficacy and safety of docetaxel and weekly-paclitaxel as 2nd-line chemotherapy for patients with unresectable or recurrent esophageal cancer.

Yuki S, Komatsu Y, Nakatsumi H, Kawamoto Y, Muranaka T, Sawada K, Tsuji Y, Hosokawa A, Nakamura M, Muto O, Sasaki T, Iwanaga I, Hatanaka K, Sato A, Eto K, Furukawa K, Tateyama M, Takahashi Y, Sogabe S, Honda T, Sakamoto N, Sakata Y.
Final analysis: Phase II trial of Irinotecan/S-1/Cetuximab (IRIS/Cet) as second line treatment in patients with KRAS exon2 wild type mCRC : HGCSG0902. -Comparison of administration interval in Cetuximab treatment.

DDW 2016
2016.5. San Diego, USA


Kawakubo K, Yane K, Eto K, Ishiwatari H, Ehira N, Haba S, Matsumoto R, Shinada K, Yamato H, Kudo T, Onodera M, Okuda T, Yoko A. Taya A Y, Kawahata S, Kubo K, Kubota Y, Kuwatani M, Kawakami H, Katanuma A, Ono M, Hayashi T, Uebayashi M, Sakamto N.
Risk of bleeding after endoscopic ultrasnography-guided fine needle aspiration for patients with antithrombotic agents; a prospective multicenter study.

Koike Y, Nishikawa S, Kudo T, Nakamura M, Ono Y, Endo A, Tsukuda Y, Ohba A, Itaya K, Matsuda C, Murai T, Atsushi Nagasaka A.
Direct spraying of L-Menthol onto the duodenal papilla for preventing post-ERCP pancreatitis.

Kuwatani M, Kawakami H, Kawakubo K, Kawahata S, Kubo K, Kubota Y, Sakamoto N.
Advantage and disadvantage of endoscopic ultrasonography-guided fistula creation as a biliary drainage method.

Mizusima T, Ohnishi S, Hosono H, Tsuda M, Ono M, Onishi R, Kato M, Sakamoto N.
Prevention of subsequent stricture formation after esophageal endoscopic submucosal dissection using conditioned medium obtained from amnion-derived mesenchymal stem cell culture.

Ono S, Matsuda K, Ehira N, Abiko S, Mizushima T, Yamamoto K, Yoshii S, Takahashi K, Kato M, Sakamoto N Gastric endoscopic submucosal dissection training for
novice operators in centers without expertise−multicenter prospective study.

Sato T.
Endoscopic obliterative therapy with cyanoacrylate glue for gastric varices.

EASL 2016
2016. 4. Barcelona, Spain


Hige S, Karino Y, Ozeki I, Yamaguchi M, Kimura M, Arakawa T, Nakajima T, Kuwata Y, Sato T, Ohmura T, Toyota J.
The real world experience of daclatasvir and asunaprevir combination therapy for more elderly patients than the clinical trial subjects with genotype 1b chronic hepatitis C.

World Congress on Osteoporosis,Osteoarthritis and Musculoskeletal Diseases
2016. 4. malaga, Spain


Muranaka T, Nakamura M, Ishiguro A, Yuki S, Murai T, Matsuda C, Oba A, Itaya K, Shigesawa T, Koike Y, Fujita Y, Endo A, Tsukuda Y, Ono Y, Kudo T, Nagasaka A, Nishikawa S, Komatsu Y.
Update analysis: Evaluation of the steroid premedication for cancer chemotherapy associated osteoporosis. (ESPRESSO-01 study)

>